The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
IGF1R and phosphorylated IGF1R in HER2-positive breast cancer.
B. Browne
No relevant relationships to disclose
J. Crown
Honoraria - Roche
Research Funding - Roche
A. J. Eustace
No relevant relationships to disclose
S. Kennedy
No relevant relationships to disclose
N. O'Brien
No relevant relationships to disclose
A. Larkin
No relevant relationships to disclose
J. Ballot
No relevant relationships to disclose
T. Mahgoub
No relevant relationships to disclose
Z. Qadir
No relevant relationships to disclose
F. Sclafani
No relevant relationships to disclose
S. F. Madden
No relevant relationships to disclose
M. J. Kennedy
No relevant relationships to disclose
M. J. Duffy
No relevant relationships to disclose
N. O'Donovan
No relevant relationships to disclose